Skip to main content
. 2017 Aug 24;8(47):82835–82841. doi: 10.18632/oncotarget.20463

Table 3. Allele frequencies in cases and controls and odds ratio estimates for non-traumatic ONFH.

SNP Gene Locus Alleles
(A/B)
MAF HWE pa value ORs 95%CI pb Value
Case Control
rs3918249 MMP9 20q13.12 T/C 0.297 0.322 0.613 0.886 0.739-1.062 0.191
rs2274755 MMP9 20q13.12 T/G 0.116 0.151 0.729 0.740 0.578-0.949 0.017*
rs3918254 MMP9 20q13.12 T/C 0.203 0.187 0.664 1.102 0.891-1.363 0.372
rs1053605 MMP2 16q12.2 T/C 0.112 0.129 0.843 0.850 0.656-1.100 0.217
rs243849 MMP2 16q12.2 T/C 0.191 0.167 1.00 1.177 0.945-1.468 0.146
rs243847 MMP2 16q12.2 C/T 0.415 0.405 0.117 1.042 0.879-1.237 0.634
rs243832 MMP2 16q12.2 C/G 0.362 0.382 0.347 0.921 0.774-1.096 0.353
rs7201 MMP2 16q12.2 C/A 0.245 0.255 0.349 0.950 0.782-1.154 0.603

SNP: single nucleotide polymorphism, HWE: Hardy-Weinberg equilibrium, OR: odds ratio, 95% CI: 95% confidence interval, MAF: minor allele frequency.

ap was calculated by fisher's exact test.

bp was calculated by Pearson Chi-squared test.

A/B=minor/major alleles.

The SNPs were excluded at HWE P level of 5%.